Asia Pacific Bovine Serum Albumin Market

Asia Pacific Bovine Serum Albumin Market Size

The Asia Pacific Bovine Serum Albumin Market size is estimated to grow from USD 63.08 million in 2024 to USD 87.78 million in 2033, representing a CAGR of 3.74%. The Asia Pacific Bovine Serum Albumin market has enormous potential and is likely to grow rapidly in the following years.

Albumin is a type of protein synthesized by the liver that is present in the blood. Bovine serum albumin and human serum albumin are obtained from bovine and human plasma, respectively. Albumin refers to a group of acidic proteins, the main function of which is to control colloidal osmotic pressure in the blood. It is found not only in body fluids, but also in the tissues and plants of mammals. Serum and plasma albumin are carbohydrate-free and constitute approximately 55% to 62% of the total protein content. Albumin is produced in the liver and secreted or spread to the blood system. They play an essential role in regulating blood volume and serve as transporters for molecules such as hormones, bile salts, ions, etc. There are three types of albumin. These are human serum albumin, bovine serum albumin and recombinant albumin, and their application depends on their characteristics. Plasma is a mainly used by-product, which includes immunoglobulins, fibrinogen, thrombin, and serum albumin. Bovine serum albumin is isolated from cow's milk and is primarily used as a blocker in the Enzyme Immunosorbent Assay (ELISA) and Western blot, as a standard for protein calibration and dissolves lipids.

Asia Pacific bovine serum albumin repairs tissue aids their growth and development and also protects the body from viruses that cause infection and disease. These factors are supposed to rise the demand for bovine serum albumin in the Asia Pacific market in the future.

Market Drivers

The Asia Pacific Bovine Serum Albumin market is improving due to changes in consumer preference for a high protein diet and high demand in the life sciences industry. Growth in the livestock sector and increased call for blood-based protein products are estimated to drive Asia Pacific Bovine Serum Albumin market. With extensive research in the pharmaceutical and biotech industries, the bioscience sector is estimated to be the fastest-growing sector. Advances in nanotechnology are rapidly increasing the delivery of medicines in life science applications. The dry sector is supposed to occupy the largest market share in the Asia Pacific Bovine Serum Albumin market during the outlook period. The dry form of bovine serum albumin has a long shelf life, so manufacturers prefer it primarily to the liquid form. These characteristics of the dry form have increased the import and export of bovine serum albumin. Bovine serum albumin is employed in cell culture protocols as well as for small molecule carriers. Globulin-free bovine serum albumin is used for electrophoresis. The company's continuous research and development has promoted Asia Pacific Bovine Serum Albumin market growth through the launch of new versions of existing products with different grades of bovine serum albumin derivatives, such as enzyme grade and food grade to improve revenue share. BSA is majorly utilized as a basic ingredient in several reagents for diagnostic applications.

Bovine serum albumin is used for the production of vaccines and is of great value for tasks related to cell culture, including effective washing and cryopreservation of cells. It is used as a stabilizer for various solubilized proteins and enzymes. Normally, bovine serum albumin precipitates in high concentrations of neutral salts (ammonium sulfate), but it coagulates easily even by heat. It is used as a nutrient in microbial or cell cultures and as a signal amplifier in biochemical analyzes. The Asia Pacific bovine serum albumin market is driven by increased use of plasma products in the food industry, advances in the collection and processing of bovine, increasing call for animal meat and protein among the population. Other boosters in the Asia Pacific bovine serum albumin market include expanding range of animal by-products in cell culture technology, increasing need for bovine serum albumin as an excipient for the pharmaceutical industry, and improving supply chain and distribution network.

Market Restraints

The main limitations of the Asia Pacific Bovine Serum Albumin market are reduced production and the greater preference for alternative products due to the increase in bovine disease. An increase in bovine disease leads to a decrease in production, which hinders the growth of the Asia Pacific market.

Segmental Analysis

Asia Pacific Bovine Serum Albumin Market By Form

• Dry
• Liquid

Asia Pacific Bovine Serum Albumin Market By Grade

• Technical & Diagnostic Grade
• Research/Reagent - Grade
• Food Grade

Asia Pacific Bovine Serum Albumin Market By Vertical

• Life Sciences Industry
• Food Industry
• Feed Industry
• Research Institutes

Asia Pacific Bovine Serum Albumin Market By Region

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

The Asia Pacific region is expected to dominate the worldwide market in the coming years. This is due to the increased use of Bovine Serum Albumin in the treatment of diseases, the presence of a large number of patients, further research and development with Asia Pacific market as an excipient, and a greater focus on strengthening the diagnosis, which are the main factors that drive the local market growth. New Zealand and Australia are the main producers of bovine serum albumin. In Japan, China, India, and Korea, the emphasis is on strengthening diagnosis, preventive care, and medical research. Due to these factors, these countries show great growth potential in the Asia Pacific Bovine Serum Albumin market. China has played an important role in the growth of Asia in recent years and will be the main driver of this regional market.

Key Players in the Market

Major Key Players in the APAC Bovine Serum Albumin Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGAA, Itoham Yonekyu Holdings Inc, Proliant Biologicals, Kraeber & Co Gmbh, Rockland Immunochemicals Inc, Rocky mountain biologicals, Bio-Techne Corporation, and Prospec-Tany Technogene Ltd

Recent Happenings in the Market

• In January 2018, Itoham Yonekyu Holdings confirmed the purchase ofAnzco Foods (New Zealand). The company helped expand the company into the bovine serum albumin market in Australia and New Zealand by gaining control of BovogenBiologicals, a subsidiary of Anzco Foods.